Simvastatin as a Neuroprotective Treatment for Moderate Parkinson's Disease

PHASE2CompletedINTERVENTIONAL
Enrollment

235

Participants

Timeline

Start Date

March 8, 2016

Primary Completion Date

November 1, 2019

Study Completion Date

December 31, 2020

Conditions
Parkinson Disease
Interventions
DRUG

Simvastatin

DRUG

Matched Placebo (for Simvastatin)

Trial Locations (24)

Unknown

Royal United Hospital, Bath

Royal Bournemouth Hospital, Bournemouth

Fairfield General Hospital, Bury

Addenbrooke's Hospital, Cambridge

St Peter's Hospital, Chertsey

Royal Devon and Exeter Hospital, Exeter

Leeds General Infirmary, Leeds

Charing Cross Hospital, London

King's College Hospital, London

Royal Free Hospital, London

Luton and Dunstable Hospital, Luton

Clinical Ageing Research Unit, Newcastle

Norfolk and Norwich University Hospital, Norwich

John Radcliffe Hospital, Oxford

Derriford Hospital, Plymouth

Royal Preston Hospital, Preston

Queen's Hospital, Romford

Rotherham General Hospital, Rotherham

Salford Royal Hospital, Salford

Royal Hallamshire Hospital, Sheffield

Royal Stoke University Hospital, Stoke-on-Trent

Musgrove Park Hospital, Taunton

Royal Cornwall Hospital, Truro

Yeovil District Hospital, Yeovil

All Listed Sponsors
collaborator

University of Plymouth

OTHER

lead

University Hospital Plymouth NHS Trust

OTHER

NCT02787590 - Simvastatin as a Neuroprotective Treatment for Moderate Parkinson's Disease | Biotech Hunter | Biotech Hunter